As of 2025-07-11, the Net Margin of Hainan Huluwa Pharmaceutical Group Co Ltd (605199.SS) is -19.4%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
Date | Value |
---|---|
2024-12-31 | -19.4% |
2023-12-31 | 0.6% |
2022-12-31 | 5.7% |
2021-12-31 | 5.3% |
2020-12-31 | 10.5% |
2019-12-31 | 9.2% |
2018-12-31 | 10.2% |
2017-12-31 | 3.4% |
- | |
- |